India · Delayed Price · Currency is INR M. K. Proteins Statistics
Total Valuation
M. K. Proteins has a market cap or net worth of INR 1.86 billion. The enterprise value is 2.23 billion.
| Market Cap | 1.86B |
| Enterprise Value | 2.23B |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
M. K. Proteins has 375.37 million shares outstanding. The number of shares has increased by 1.07% in one year.
| Current Share Class | 375.37M |
| Shares Outstanding | 375.37M |
| Shares Change (YoY) | +1.07% |
| Shares Change (QoQ) | +6.08% |
| Owned by Insiders (%) | 61.88% |
| Owned by Institutions (%) | n/a |
| Float | 94.50M |
Valuation Ratios
The trailing PE ratio is 27.56.
| PE Ratio | 27.56 |
| Forward PE | n/a |
| PS Ratio | 0.49 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 2.44 |
| P/FCF Ratio | 52.62 |
| P/OCF Ratio | 34.26 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.09, with an EV/FCF ratio of 62.99.
| EV / Earnings | 32.64 |
| EV / Sales | 0.58 |
| EV / EBITDA | 19.09 |
| EV / EBIT | 19.83 |
| EV / FCF | 62.99 |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.49.
| Current Ratio | 2.25 |
| Quick Ratio | 0.05 |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 3.18 |
| Debt / FCF | 10.50 |
| Interest Coverage | 6.07 |
Financial Efficiency
Return on equity (ROE) is 9.37% and return on invested capital (ROIC) is 8.87%.
| Return on Equity (ROE) | 9.37% |
| Return on Assets (ROA) | 5.37% |
| Return on Invested Capital (ROIC) | 8.87% |
| Return on Capital Employed (ROCE) | 14.29% |
| Weighted Average Cost of Capital (WACC) | 4.48% |
| Revenue Per Employee | 76.58M |
| Profits Per Employee | 1.37M |
| Employee Count | 50 |
| Asset Turnover | 2.93 |
| Inventory Turnover | 3.33 |
Taxes
In the past 12 months, M. K. Proteins has paid 25.60 million in taxes.
| Income Tax | 25.60M |
| Effective Tax Rate | 27.26% |
Stock Price Statistics
The stock price has decreased by -44.62% in the last 52 weeks. The beta is 0.07, so M. K. Proteins's price volatility has been lower than the market average.
| Beta (5Y) | 0.07 |
| 52-Week Price Change | -44.62% |
| 50-Day Moving Average | 5.11 |
| 200-Day Moving Average | 5.80 |
| Relative Strength Index (RSI) | 49.13 |
| Average Volume (20 Days) | 144,683 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, M. K. Proteins had revenue of INR 3.83 billion and earned 68.29 million in profits. Earnings per share was 0.18.
| Revenue | 3.83B |
| Gross Profit | 144.45M |
| Operating Income | 112.41M |
| Pretax Income | 93.89M |
| Net Income | 68.29M |
| EBITDA | 116.77M |
| EBIT | 112.41M |
| Earnings Per Share (EPS) | 0.18 |
Balance Sheet
The company has 4.38 million in cash and 371.38 million in debt, with a net cash position of -367.00 million or -0.98 per share.
| Cash & Cash Equivalents | 4.38M |
| Total Debt | 371.38M |
| Net Cash | -367.00M |
| Net Cash Per Share | -0.98 |
| Equity (Book Value) | 763.00M |
| Book Value Per Share | 2.01 |
| Working Capital | 656.85M |
Cash Flow
In the last 12 months, operating cash flow was 54.34 million and capital expenditures -18.95 million, giving a free cash flow of 35.39 million.
| Operating Cash Flow | 54.34M |
| Capital Expenditures | -18.95M |
| Depreciation & Amortization | 4.36M |
| Net Borrowing | -16.83M |
| Free Cash Flow | 35.39M |
| FCF Per Share | 0.09 |
Margins
Gross margin is 3.77%, with operating and profit margins of 2.94% and 1.78%.
| Gross Margin | 3.77% |
| Operating Margin | 2.94% |
| Pretax Margin | 2.45% |
| Profit Margin | 1.78% |
| EBITDA Margin | 3.05% |
| EBIT Margin | 2.94% |
| FCF Margin | 0.92% |
Dividends & Yields
M. K. Proteins does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.07% |
| Shareholder Yield | -1.07% |
| Earnings Yield | 3.67% |
| FCF Yield | 1.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 15, 2024. It was a forward split with a ratio of 3.
| Last Split Date | Mar 15, 2024 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |